# Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

> **NCT00957034** · PHASE2 · TERMINATED · sponsor: **Warner Chilcott** · enrollment: 17 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** placebo
- **DRUG:** testosterone

## Key facts

- **NCT ID:** NCT00957034
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Due to difficult patient enrollment.
- **Last updated:** 2012-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957034, "Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00957034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*